Cloud labelling and serialisation: the new frontline of traceability in drug delivery

Published: 17-Sep-2025
Packaging Regulatory

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence

You need to be a subscriber to read this article.
Click here to find out more.

With expectations rising for distributors, suppliers and manufacturers, robust cloud labelling and serialisation solutions are making strides to enhance traceability, streamline recalls, prevent counterfeits and guarantee safe and compliant delivery to patients.  

Laura Johnson, Senior Sales Director at Loftware, reports.

Counterfeiting prevention and quality control  

According to the World Health Organization (WHO), approximately 10% of medical products circulating in low- and middle-income nations fail quality control tests, which could suggest falsification. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Packaging

Loftware and Tenthpin collaborate on clinical supply labelling

Read more
The partnership supports mutual customers at a time when clinical trial supplies teams are coming under increasing pressure from pharmaceutical organisations.

Trending Articles

  1. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste
  2. ProMach Pharma presents new equipment at Pack Expo Las Vegas Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
  3. Balancing innovation and accessibility in amino acid testing Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Quality management during manufacturing changes: part I Change is a universal constant and continues to accelerate in the realms of pharmaceutical, medical device and in-vitro diagnostic manufacturers who face ever-increasing pressure to optimise costs while maintaining high product quality and patient safety standards
  5. NICE recommends enfortumab vedotin with KEYTRUDA for adults in England/Wales with untreated metastatic urothelial cancer The results from the Phase III study EV-302/KN-A39 showed nearly a doubling of survival rates in patients compared with those who received platinum-based chemotherapy, which is the current standard of care in the UK

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Packaging

Loftware and Tenthpin collaborate on clinical supply labelling

The partnership supports mutual customers at a time when clinical trial supplies teams are coming under increasing pressure from pharmaceutical organisations.
Packaging

How labelling can mitigate supply chain disruptions for medical device manufacturers

Since March 2020, medical device companies have needed to withstand unique challenges; companies across every vertical — from PPE, ventilator, vaccine and syringe manufacturers to those that are not COVID-specific — have been affected by the pandemic and consequent supply chain disruptions
Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
Regulatory

Novo Nordisk’s oral semaglutide scores EU approval for cardiovascular benefits

Rybelsus is now the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Manufacturing

Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision

Partnership delivers compliance confidence, efficiency gains and reduced waste
Packaging

ProMach Pharma presents new equipment at Pack Expo Las Vegas

Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
Regulatory

New NICE thresholds: good news for rare disease drugs but process remains complex

Recent changes introduced by NICE will ultimately see more ultra-rare disease drugs get to market, but Dan Williams, CEO at SynaptixBio, says the process remains challenging
Subscribe now